These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 11019584)
1. [Concurrent chemoradiotherapy for locally unresectable head and neck cancer]. Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Itoh Y; Murata Y; Furukawa T Nihon Jibiinkoka Gakkai Kaiho; 2000 Aug; 103(8):894-9. PubMed ID: 11019584 [TBL] [Abstract][Full Text] [Related]
2. Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer. Kohno N; Kitahara S; Tamura E; Tanabe T Oncology; 2002; 63(3):226-31. PubMed ID: 12381901 [TBL] [Abstract][Full Text] [Related]
3. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck. Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216 [TBL] [Abstract][Full Text] [Related]
4. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil. Wibault P; Bensmaine MA; de Forni M; Armand JP; Tellez Bernal E; Guillot T; Recondo G; Domenge C; Janot F; Borel C; Luboinski B; Eschwege F; Cvitkovic E J Clin Oncol; 1996 Apr; 14(4):1192-200. PubMed ID: 8648374 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256 [TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029 [TBL] [Abstract][Full Text] [Related]
7. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937 [TBL] [Abstract][Full Text] [Related]
8. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck. Tsukuda M; Ishitoya J; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Nishimura G; Kawakami M; Watanabe M; Niho T; Kawano T; Ikeda Y; Sakuma Y; Shiono O; Komatsu M Cancer Chemother Pharmacol; 2010 Sep; 66(4):729-36. PubMed ID: 20033810 [TBL] [Abstract][Full Text] [Related]
9. Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol. Abitbol A; Abdel-Wahab M; Lewin A; Troner M; Rodrigues MA; Hamilton-Nelson KL; Markoe A Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):942-7. PubMed ID: 12095561 [TBL] [Abstract][Full Text] [Related]
10. Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). Rischin D; Peters L; Fisher R; Macann A; Denham J; Poulsen M; Jackson M; Kenny L; Penniment M; Corry J; Lamb D; McClure B J Clin Oncol; 2005 Jan; 23(1):79-87. PubMed ID: 15625362 [TBL] [Abstract][Full Text] [Related]
11. Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer. Humerickhouse RA; Dolan ME; Haraf DJ; Brockstein B; Stenson K; Kies M; Sulzen L; Ratain MJ; Vokes EE Clin Cancer Res; 1999 Feb; 5(2):291-8. PubMed ID: 10037177 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568 [TBL] [Abstract][Full Text] [Related]
13. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Katori H; Tsukuda M; Taguchi T Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926 [TBL] [Abstract][Full Text] [Related]
14. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy. Langer CJ; Duffy K; Horwitz EM; Litwin S; Rosvold E; Schol J; Keenan E; Nicolaou N; Friedman CD; Ridge JA Cancer Invest; 2006 Mar; 24(2):164-73. PubMed ID: 16537186 [TBL] [Abstract][Full Text] [Related]
15. Chemoradiation for locally advanced squamous cell carcinoma of the head and neck for organ preservation and palliation. Poole ME; Sailer SL; Rosenman JG; Tepper JE; Weissler MC; Shockley WW; Yarbrough WG; Pillsbury HC; Schell MJ; Bernard SA Arch Otolaryngol Head Neck Surg; 2001 Dec; 127(12):1446-50. PubMed ID: 11735812 [TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy for unresectable recurrent or metastatic squamous cell carcinomas of the head and neck]. Nishino H; Fujisawa Y; Kanazawa T; Ishikawa K; Miyata M; Ichimura K; Abe K; Tanaka H Nihon Jibiinkoka Gakkai Kaiho; 2000 Sep; 103(9):963-9. PubMed ID: 11070972 [TBL] [Abstract][Full Text] [Related]
17. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)]. Tahara M Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996 [TBL] [Abstract][Full Text] [Related]
18. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study. Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711 [TBL] [Abstract][Full Text] [Related]
19. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658 [TBL] [Abstract][Full Text] [Related]
20. Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer. Lee YJ; Lee CG; Cho BC; Kim GE; Choi HJ; Choi EC; Sohn JH; Kim JH Head Neck; 2010 Feb; 32(2):235-43. PubMed ID: 19572288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]